0      0

29th Annual North American Cystic Fibrosis Conference

W14: NT: Early Studies of Novel Small Molecule Therapies

Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

Standard: $49.99


This session will consider novel small molecule therapeutic approaches directed at CF relevant drug targets, including delF508-CFTR, epithelial sodium channels & less frequent CFTR mutations. The session provides perspectives from academic & industrial laboratories.

Educational Objectives:

  1. Discuss innovative approaches to restore the expression, stability & function of delF508-CFTR.
  2. Review the challenges of developing rational new therapies for rare CF mutations.
  3. Explain the therapeutic potential for CF lung disease of small molecules that modify ENaC function.


You must be logged in and own this session in order to post comments.